Evidence map›Paper›PMID 31413139›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2019

Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment.

Sarah L Withey, Roger D Spealman, Jack Bergman, Carol A Paronis

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Translational In Vivo Assays in Behavioral Biology.Annual review of pharmacology and toxicology · 2024
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sarah L WitheyBehavioral Biology Program, McLean Hospital/Harvard Medical School, Belmont, Massachusetts.
Roger D SpealmanBehavioral Biology Program, McLean Hospital/Harvard Medical School, Belmont, Massachusetts.
Jack BergmanBehavioral Biology Program, McLean Hospital/Harvard Medical School, Belmont, Massachusetts.
Carol A ParonisBehavioral Biology Program, McLean Hospital/Harvard Medical School, Belmont, Massachusetts cparonis@mclean.harvard.edu.
Harvard University · USMcLean Hospital · US

Funding

Pharmacologic Approaches to Prescription Opioid Addiction and Relapse PreventionR01DA035857 · NIDA · MCLEAN HOSPITAL · PI BERGMAN, JACK, SPEALMAN, ROGER D · 2014 to 2018
$2.3M
NIDA NIH HHS R01 DA035857
6 · The paper itself

Abstract

Buprenorphine, a partial agonist at the

Indexed as

Drug Partial AgonismAnalgesics, OpioidAnimalsBehavior, AddictiveBuprenorphineDose-Response Relationship, DrugMaleMorphineOxycodonePain MeasurementReceptors, Opioid, muSaimiriSelf AdministrationAnalgesics, OpioidBuprenorphineMorphineOxycodoneReceptors, Opioid, mu

Identifiers

PMID31413139
PMCPMC6863455
OpenAlexW2968729053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.